SBICAP Trustee Releases Pledge on 44.35% Stake in Nectar Lifesciences

In a significant corporate action, SBICAP Trustee Company Limited has released its pledge on a substantial portion of Nectar Lifesciences Limited's equity shares. This move has resulted in a notable change in the shareholding pattern of the pharmaceutical company.

Key Details of the Pledge Release

Aspect	Details
Shares Released	9,94,68,000 equity shares
Percentage of Total Voting Capital	44.35%
Date of Release	October 30, 2025
SBICAP Trustee's Holding Post-Release	Nil

Impact on Shareholding

The release of pledge has led to a complete exit of SBICAP Trustee Company Limited from Nectar Lifesciences' shareholding structure. Prior to this action, SBICAP Trustee held a significant 44.35% stake in the company through pledged shares.

Company Share Capital

Nectar Lifesciences Limited's share capital structure remains unchanged:

Aspect	Details
Total Equity Shares	19,94,68,000
Face Value per Share	Rs. 1.00
Total Share Capital	Rs. 9,94,68,000

Additional Information

It's important to note that SBICAP Trustee Company Limited does not belong to the promoter group of Nectar Lifesciences. This pledge release was executed in compliance with regulatory requirements, as evidenced by the disclosure made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The official communication regarding this transaction was sent to the BSE Limited on November 3, 2025, by SBICAP Trustee Company Limited, detailing the release of pledge and the subsequent change in shareholding.

This development may have implications for Nectar Lifesciences' ownership structure and could potentially impact the company's future strategic decisions. Investors and market watchers will likely keep a close eye on any further developments or changes in the company's shareholding pattern following this significant pledge release.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-4.90%	+3.15%	+2.50%	-32.74%	-62.84%	-19.40%

Nectar Lifesciences Limited , a prominent player in the pharmaceutical industry, has announced a significant development regarding its promoters' shareholding. The company disclosed that two of its key promoters, Sanjiv Goyal and Sanjiv HUF, have released a substantial number of pledged shares.

Details of the Pledge Release

Promoter	Shares Released	Shareholding (%)	Value (₹ in Crore)
Sanjiv Goyal	55,84,560	24.90	88.01
Sanjiv HUF	43,62,240	19.45	68.75
Total	99,46,800	44.35	156.76

The pledge release was executed by SBICAP Trustee Company Limited, acting as the security trustee for the company's lenders.

Impact on Shareholding

It's important to note that this development does not alter the actual ownership of shares by the promoters. Both Sanjiv Goyal and Sanjiv HUF have maintained their respective shareholding percentages. The transaction solely involves the release of previously pledged shares.

Regulatory Compliance

In compliance with the Securities and Exchange Board of India (SEBI) regulations, specifically the Prohibition of Insider Trading Regulations, 2015, Nectar Lifesciences has duly filed the required disclosures. The promoters submitted Form B, detailing the changes in their securities holding, which the company then reported to the stock exchanges.

This move by Nectar Lifesciences' promoters to release a significant portion of their pledged shares may be viewed as a notable development in the company's financial landscape. However, the full impact of this action on the company's future performance remains to be seen.